SRA® for Inpatient Stroke Unit Monitoring

About Apoplex Medical Technologies

Apoplex Medical Technologies has developed SRA®, a validated, AI-based software platform for the automated detection of atrial fibrillation (AF) from ECG data, primarily targeting stroke units. The technology claims to double the detection rate of paroxysmal AF in one-third the time of conventional methods, thereby addressing a critical gap in stroke prevention. Trusted by over 200 clinics globally, including 40% of stroke units in Germany, the company offers a 'zero-click' workflow that reduces clinical workload and enables faster, data-driven patient management decisions. Its business model is commercial, generating revenue through the sale of its diagnostic analysis service to hospitals.

Therapeutic Areas